| 28/04/20 | 11:06:07 | 28 Apr 2020 | | Second Price Monitoring Extn | RNS |
| 28/04/20 | 11:00:43 | 28 Apr 2020 | | Price Monitoring Extension | RNS |
| 27/04/20 | 16:41:17 | 27 Apr 2020 | | Second Price Monitoring Extn | RNS |
| 27/04/20 | 16:36:28 | 27 Apr 2020 | | Price Monitoring Extension | RNS |
| 27/04/20 | 14:06:09 | 27 Apr 2020 | | Second Price Monitoring Extn | RNS |
| 27/04/20 | 14:00:24 | 27 Apr 2020 | | Price Monitoring Extension | RNS |
| 22/04/20 | 16:40:49 | 22 Apr 2020 | | Second Price Monitoring Extn | RNS |
| 22/04/20 | 16:35:25 | 22 Apr 2020 | | Price Monitoring Extension | RNS |
| 22/04/20 | 14:05:50 | 22 Apr 2020 | | Second Price Monitoring Extn | RNS |
| 22/04/20 | 14:00:34 | 22 Apr 2020 | | Price Monitoring Extension | RNS |
| 22/04/20 | 11:00:01 | 22 Apr 2020 | | COVID-19 Project Initiated | RNS |
| 21/04/20 | 14:26:50 | 21 Apr 2020 | | Approval and Issuance of European Hu-PHEC Patent | RNS |
| 02/04/20 | 15:05:42 | 2 Apr 2020 | | Second Price Monitoring Extn | RNS |
| 02/04/20 | 15:00:40 | 2 Apr 2020 | | Price Monitoring Extension | RNS |
| 28/02/20 | 18:30:01 | 28 Feb 2020 | | Total Voting Rights | RNS |
| 20/02/20 | 07:00:07 | 20 Feb 2020 | | HEMO-CAR-T cells Effective Against AML in vivo | RNS |
| 11/02/20 | 07:00:06 | 11 Feb 2020 | | Approval and Issuance of U.S. Hu-PHEC Patent | RNS |
| 31/01/20 | 07:00:05 | 31 Jan 2020 | | Director/PDMR Shareholding | RNS |
| 30/01/20 | 14:05:08 | 30 Jan 2020 | | Placing and Subscription to raise £650,000 | RNS |
| 15/01/20 | 12:30:01 | 15 Jan 2020 | | HEMO's CAR-T Cells Effective Against AML in vitro | RNS |
| 18/11/19 | 07:00:07 | 18 Nov 2019 | | Operational Update | RNS |
| 12/11/19 | 07:00:01 | 12 Nov 2019 | | Presentation at the Investival Showcase | RNS |
| 06/11/19 | 07:00:05 | 6 Nov 2019 | | Presentation at the NY Oncology Investor Conf. | RNS |
| 23/10/19 | 08:00:03 | 23 Oct 2019 | | Research Agreement with Global Pharma Company | RNS |
| 21/10/19 | 08:00:08 | 21 Oct 2019 | | Presentation at NY Stem Cell Foundation conference | RNS |
| 30/09/19 | 08:00:11 | 30 Sept 2019 | | Half-year Report | RNS |
| 12/09/19 | 08:00:13 | 12 Sept 2019 | | Hemogenyx scientific advisor receives Lasker Award | RNS |
| 01/08/19 | 08:00:04 | 1 Aug 2019 | | Total Voting Rights | RNS |
| 12/07/19 | 08:00:04 | 12 Jul 2019 | | CDX Patent Application | RNS |
| 28/06/19 | 13:19:22 | 28 Jun 2019 | | Result of AGM | RNS |
| 24/06/19 | 08:00:09 | 24 Jun 2019 | | Development of ApbHC | RNS |
| 12/06/19 | 08:00:02 | 12 Jun 2019 | | CDX Effective as Conditioning Therapeutic in vivo | RNS |
| 05/06/19 | 09:15:05 | 5 Jun 2019 | | CDX Antibody is Effective against AML in vivo | RNS |
| 30/05/19 | 17:40:35 | 30 May 2019 | | Second Price Monitoring Extn | RNS |
| 30/05/19 | 17:35:46 | 30 May 2019 | | Price Monitoring Extension | RNS |
| 30/05/19 | 08:00:04 | 30 May 2019 | | CDX Antibody is Effective against ALL in vitro | RNS |
| 28/05/19 | 08:00:09 | 28 May 2019 | | Posting of Annual Report and Notice of AGM | RNS |
| 15/05/19 | 08:00:03 | 15 May 2019 | | Variation of Terms of Warrant Instrument | RNS |
| 01/05/19 | 08:00:14 | 1 May 2019 | | Director/PDMR Shareholding | RNS |
| 29/04/19 | 16:10:17 | 29 Apr 2019 | | Final Results for the Year Ended 31 December 2018 | RNS |
| 30/01/19 | 07:00:02 | 30 Jan 2019 | | Presentation at Cancer Immunotherapy Conference | RNS |
| 07/01/19 | 07:00:04 | 7 Jan 2019 | | Operations Update | RNS |
| 20/12/18 | 07:00:06 | 20 Dec 2018 | | Directorate Change | RNS |
| 05/11/18 | 07:00:06 | 5 Nov 2018 | | Directorate Change & Appointment | RNS |
| 22/10/18 | 08:00:06 | 22 Oct 2018 | | Orgenesis collaboration for Hu-PHEC development | RNS |
| 15/10/18 | 08:00:04 | 15 Oct 2018 | | Collaboration with Johnson & Johnson Innovation | RNS |
| 28/09/18 | 10:30:03 | 28 Sept 2018 | | Half-year Report | RNS |
| 28/09/18 | 08:00:12 | 28 Sept 2018 | | Change of Adviser | RNS |
| 03/09/18 | 08:00:06 | 3 Sept 2018 | | Hemogenyx to present at Oxford conference | RNS |
| 27/06/18 | 12:39:56 | 27 Jun 2018 | | Result of AGM | RNS |
